Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
opioid
|
| gptkbp:activeIngredient |
gptkb:oxymorphone
|
| gptkbp:administeredBy |
injection
oral |
| gptkbp:approvedBy |
1959
|
| gptkbp:ATCCode |
N02AA05
|
| gptkbp:brand |
gptkb:oxymorphone
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| https://www.w3.org/2000/01/rdf-schema#label |
Numorphan
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Endo_Pharmaceuticals
|
| gptkbp:sideEffect |
nausea
constipation drowsiness respiratory depression |
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:oxymorphone
|
| gptkbp:bfsLayer |
7
|